packageBortezomib

bortezomib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bortezomib is an anticancer medicine (a proteasome inhibitor) used mainly to treat multiple myeloma and other blood cancers such as mantle cell lymphoma. It is approved and widely used, with several authorised products in the European Union, though it is typically given under specialist oncology care.

Summary written by glm-5.3-flash from Wikidata Q419319 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:bortezomib
ATC codes:L01XG01, L01XX32
DrugBank:DB00188
PubChem CID:387447
ChEBI:52717
Wikidata:Q419319
formula:C19H25BN4O4
molar mass:384.243 g/mol (PubChem CID 387447)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown